BlackRock discloses 12.7% of Artivion (AORT), 5,977,264 shares
BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 5,977,264 shares of Artivion, Inc. (AORT) common stock, representing 12.7% of the class as of 09/30/2025.
Rhea-AI Filing Summary
BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 5,977,264 shares of Artivion, Inc. (AORT) common stock, representing 12.7% of the class as of 09/30/2025.
BlackRock reports sole voting power over 5,912,256 shares and sole dispositive power over 5,977,264 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control. The interest of iShares Core S&P Small-Cap ETF in Artivion’s common stock is noted as more than five percent of outstanding shares.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake did BlackRock report in Artivion (AORT)?
What is the date tied to this ownership report for AORT?
Did BlackRock indicate any intent to influence control at Artivion?
Which BlackRock-affiliated fund holds over 5% of AORT?
AI-generated analysis. How Rhea-AI works. Not financial advice.